1) hepatocellular jaundice
肝细胞黄疸
1.
Continuous transarterial infusion chemotherapy with Aidi combined with transhepatic arterial embolism in treatment of liver malignant tumor with hepatocellular jaundice
艾迪持续动脉灌注联合栓塞治疗伴有肝细胞黄疸的肝脏恶性肿瘤
2) hepatocellular jaundice
肝细胞性黄疸
1.
Objective:To explore the theoretical basis on the pathogeny and pathogenesisand treatment based on categorical identification of Hepatocellular jaundice; combined with epidemiological investigation, this thesis anslyze the Syndrome discipline of Chinese medicine and analysis of relevant factor from the regularity study of Hepatocellular jaundice.
目的:探讨肝细胞性黄疸病因病机、辨证治疗的理论依据;结合临床流行病学调查,通过对肝细胞性黄疸的规律性研究,分析探索该病的中医证候特点及其相关影响因素。
2.
Hepatobiliary jaundice can be divided into subcellular jaundice, hepatocellular jaundice, cholangio-jaundice, and mixture.
按其发生病变的组织部位可细分为亚细胞性黄疸、肝细胞性黄疸、胆管性黄疸和混合性黄疸。
3) parenchymal jaundice
肝细胞性黄疸;实质性黄疸
4) subcellular jaundice
亚细胞性黄疸
1.
Hepatobiliary jaundice can be divided into subcellular jaundice, hepatocellular jaundice, cholangio-jaundice, and mixture.
按其发生病变的组织部位可细分为亚细胞性黄疸、肝细胞性黄疸、胆管性黄疸和混合性黄疸。
5) heptogenic jaundice
肝性黄疸
补充资料：急性黄疸型肝炎
急性黄疸型肝炎
参见"急性肝炎"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条